flecainide has been researched along with Liver Cirrhosis in 1 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hepatic biotransformation capability before flecainide dosing was assessed by antipyrine challenge." | 1.27 | Pharmacokinetics of flecainide in patients with cirrhosis of the liver. ( Chang, SF; Conard, GJ; McQuinn, RL; Pentikäinen, PJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McQuinn, RL | 1 |
| Pentikäinen, PJ | 1 |
| Chang, SF | 1 |
| Conard, GJ | 1 |
1 other study available for flecainide and Liver Cirrhosis
| Article | Year |
|---|---|
Pharmacokinetics of flecainide in patients with cirrhosis of the liver.
Topics: Adult; Aged; Antipyrine; Biotransformation; Female; Flecainide; Humans; Liver; Liver Cirrhosis; Male | 1988 |